Companies / Oramed Pharmaceuticals Inc. / Activity
Activity — Oramed Pharmaceuticals Inc.
25 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BML Capital Management, LLC 13F manager | Trim | Common stock | $-11.07M | -2.3M -72.65% | 866,269 2.08% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $7.30M | +1.5M +1682.59% | 1,608,111 3.87% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common stock | $1.16M | +242K | 242,100 0.58% of shares | low |
| Q1 2026 as of | Hillsdale Investment Management Inc. 13F manager | New | Common stock | $330.8K | +97K | 97,300 0.23% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $175.7K | +52K | 51,670 0.12% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $159.7K | +33K | 33,198 0.08% of shares | low |
| Q1 2026 as of | RBF Capital, LLC 13F manager | Exit | Common stock | $-122.4K | -43K -100.00% | 0 | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Exit | Common stock | $-118.9K | -42K -100.00% | 0 | low |
| Q1 2026 as of | OMERS Administration Corporation 13F manager | New | Common stock | $62.6K | +18K | 18,400 0.04% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common stock | $54.5K | +16K | 16,018 0.04% of shares | low |
| Q1 2026 as of | Prelude Capital Management, LLC 13F manager | Add | Common stock | $46.6K | +14K +63.39% | 35,313 0.08% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-41.7K | -19K -48.09% | 20,649 0.05% of shares | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | Exit | Common stock | $-37.6K | -13K -100.00% | 0 | low |
| Q1 2026 as of | Mariner, LLC 13F manager | Exit | Common stock | $-31.4K | -11K -100.00% | 0 | low |
| Q2 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-26.5K | -7K -35.89% | 13,239 0.03% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | Common stock | $-21.2K | -7K -4.96% | 142,243 0.34% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-17.9K | -6K -47.59% | 6,917 0.02% of shares | low |
| Q3 2023 as of | Barclays PLC 13F manager | Add | Common stock | $13.5K | +5K +39.03% | 18,406 0.04% of shares | low |
| Q4 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-11.9K | -5K -28.07% | 13,239 0.03% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | Common stock | $1.9K | +556 +0.21% | 259,611 0.62% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common stock | $1.0K | +174 | 174 <0.01% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common stock | $680 | +200 +0.14% | 147,700 0.36% of shares | low |
| Q1 2026 as of | Northwestern Mutual Wealth Management Co 13F manager | Trim | Common stock | $-445 | -131 -7.68% | 1,575 <0.01% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | Trim | Common stock | $-99 | -41 -0.31% | 13,198 0.03% of shares | low |
| Q1 2026 as of | Algert Global LLC 13F manager | Add | Common stock | $24 | +7K +59.25% | 19,218 0.05% of shares | low |